Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>Argo Biopharma Considering HK IPO to Raise $2.34B: Rumor
Recommend 5 Positive 16 Negative 6 |
||||
|
||||
|
Chinese biotech company, Argo Biopharma, is considering an IPO in Hong Kong to raise approx. US$300 million (equivalent to about $2.34 billion), Reuters' IFR quoted sources as saying. Argo Biopharma was established in April 2021, and is a clinical-stage biotechnology company committed to developing next-generation siRNA therapeutics to provide better treatment options for patients worldwide, according to the company's website. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
